Ketamine enhances the expression of serine racemase and d-amino acid oxidase mRNAs in rat brain

European Journal of Pharmacology

Volumn 540, Issue 1-3, 2006, Pages 82-86

  Takeyama, Kazuhide ^a   Yoshikawa, Masanobu ^a   Oka, Tetsuo ^a   Kawaguchi, Mitsuru ^b   Suzuki, Toshiyasu ^a   Hashimoto, Atsushi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Anesthetics; d Amino acid oxidase; Ketamine; NMDA receptor; Schizophrenia; Serine racemase

Indexed keywords

DEXTRO AMINO ACID OXIDASE; ENZYME; KETAMINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SERINE RACEMASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANESTHETICS, DISSOCIATIVE; ANIMALS; BRAIN; CEREBELLUM; CEREBRAL CORTEX; CORPUS STRIATUM; D-AMINO-ACID OXIDASE; DIENCEPHALON; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; KETAMINE; MALE; MESENCEPHALON; PONS; RACEMASES AND EPIMERASES; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 33744993609     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.04.021     Document Type: Article

References (35)

1. Becker A., Peters B., Schroeder H., Mann T., Huether G., and Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog. Neuro-psychopharmacol. Biol. Psychiatry 27 (2003) 687-700
2. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim L., Bougueleret H., Barry C., Tanaka H., and La Rosa P. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13675-13680
3. Contreras P.C. d-Serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia. Neuropharmacology 29 (1990) 291-293
4. Coyle J.T., and Tsai G. The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berlin) 174 (2004) 32-38
5. Deutsch S.I., Mastropaolo J., Schwartz B.L., Rosse R.B., and Morihisa J.M. A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine. Clin. Neuropharmacol. 12 (1989) 1-13
6. Duncan E.J., Madonick S.H., Parwani A., Angrist B., Rajan R., Chakravorty S., Efferen T.R., Szilagyi S., Stephanides M., Chappell P.B., Gonzenbach S., Ko G.N., and Rotrosen J.P. Clinical and sensorimotor gating effects of ketamine in normals. Neuropsychopharmacology 25 (2001) 72-83
7. Follesa P., and Ticku M.K. NMDA receptor upregulation: molecular studies in cultured mouse cortical neurons after chronic antagonist exposure. J. Neurosci. 16 (1996) 2172-2178
8. Fukui K., and Miyake Y. Molecular cloning and chromosomal localization of a human gene encoding d-amino-acid oxidase. J. Biol. Chem. 267 (1992) 18631-18638
9. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68
10. Hashimoto A., and Oka T. Free d-aspartate and d-serine in the mammalian brain and periphery. Prog. Neurobiol. 52 (1997) 325-353
11. Hashimoto A., Nishikawa T., Konno R., Niwa A., Yasumura Y., Oka T., and Takahashi K. Free d-serine, d-aspartate and d-alanine in central nervous system and serum in mutant mice lacking d-amino acid oxidase. Neurosci. Lett. 152 (1993) 33-36
12. Hashimoto A., Nishikawa T., Oka T., and Takahashi K. Endogenous d-serine in rat brain: N-methyl-d-aspartate receptor-related distribution and aging. J. Neurochem. 60 (1993) 783-786
13. Hashimoto A., Oka T., and Nishikawa T. Extracellular concentration of endogenous free d-serine in the rat brain as revealed by in vivo microdialysis. Neuroscience 66 (1995) 635-643
14. Hashimoto A., Yoshikawa M., Niwa A., and Konno R. Mice lacking d-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801. Brain Res. 1033 (2005) 210-215
15. Horiike K., Tojo H., Arai R., Nozaki M., and Maeda T. d-Amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes. Brain Res. 652 (1994) 297-303
16. Hughes P., and Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47 (1995) 133-178
17. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148 (1991) 1301-1308
18. Johnson K.M., and Jones S.M. Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 707-750
19. 2 receptors: implications for models of schizophrenia. Mol. Psychiatry 7 (2002) 837-844
20. Kartvelishvily, E., Shleper, M., Balan, L., Dumin, E., Wolosker, H., (in press).Neuron-derived d-serine: Novel means to activate N-methyl-d-aspartate receptors. J. Biol. Chem.
21. Kim H.C., Bing G., Jhoo W.K., Ko K.H., Kim W.K., Lee D.C., Shin E.J., and Hong J.S. Dextromethorphan modulates the AP-1 DNA-binding activity induced by kainic acid. Brain Res. 824 (1999) 125-132
22. Konno R. Rat cerebral serine racemase: amino acid deletion and truncation at carboxy terminus. Neurosci. Lett. 349 (2003) 111-114
23. Kontkanen O., Lakso M., Koponen E., Wong G., and Castren E. Molecular effects of the psychotropic NMDA receptor antagonist MK-801 in the rat entorhinal cortex: increases in AP-1 DNA binding activity and expression of Fos and Jun family members. Ann. N.Y. Acad. Sci. 911 (2000) 73-82
24. Matsui T., Sekiguchi M., Hashimoto A., Tomita U., Nishikawa T., and Wada K. Functional comparison of d-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration. J. Neurochem. 65 (1995) 454-458
25. McDonald J.W., Silverstein F.S., and Johnston M.V. MK-801 pretreatment enhances N-methyl-d-aspartate-mediated brain injury and increases brain N-methyl-d-aspartate recognition site binding in rats. Neuroscience 38 (1990) 103-113
26. Mohn A.R., Gainetdinov R.R., Caron M.G., and Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98 (1999) 427-436
27. Schell M.J., Molliver M.E., and Snyder S.H. d-Serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3948-3952
28. Storvik M., Linden A.M., Kontkanen O., Lakso M., Castren E., and Wong G. Induction of cAMP response element modulator (CREM) and inducible cAMP early repressor (ICER) expression in rat brain by uncompetitive N-methyl-d-aspartate receptor antagonists. J. Pharmacol. Exp. Ther. 294 (2000) 52-60
29. Tanii Y., Nishikawa T., Hashimoto A., and Takahashi K. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J. Pharmacol. Exp. Ther. 269 (1994) 1040-1048
30. Tsai G., Yang P., Chung L.C., Lange N., and Coyle J.T. d-Serine added to antipsychotics for the treatment of schizophrenia. Biol. Psychiatry 44 (1998) 1081-1089
31. Williams K., Dichter M.A., and Molinoff P.B. Up-regulation of N-methyl-d-aspartate receptors on cultured cortical neurons after exposure to antagonists. Mol. Pharmacol. 42 (1992) 147-151
32. Wolosker H., Blackshaw S., and Snyder S.H. Serine racemase: a glial enzyme synthesizing d-serine to regulate glutamate-N-methyl-d-aspartate neurotransmission. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13409-13414
33. Wu S., and Barger S.W. Induction of serine racemase by inflammatory stimuli is dependent on AP-1. Ann. N.Y. Acad. Sci. 1035 (2004) 133-146
34. Yoshikawa M., Kobayashi T., Oka T., Kawaguchi M., and Hashimoto A. Distribution and MK-801-induced expression of serine racemase mRNA in rat brain by real-time quantitative PCR. Mol. Brain Res. 128 (2004) 90-94
35. Yoshikawa M., Oka T., Kawaguchi M., and Hashimoto A. MK-801 upregulates the expression of d-amino acid oxidase mRNA in rat brain. Mol. Brain Res. 131 (2004) 141-144